The inward rectification mechanism of the HERG cardiac potassium channel

Nature
P L SmithG Yellen

Abstract

A human genetic defect associated with 'long Q-T syndrome', an abnormality of cardiac rhythm involving the repolarization of the action potential, was recently found to lie in the HERG gene, which codes for a potassium channel. The HERG K+ channel is unusual in that it seems to have the architectural plan of the depolarization-activated K+ channel family (six putative transmembrane segments), yet it exhibits rectification like that of the inward-rectifying K+ channels, a family with different molecular structure (two transmembrane segments). We have studied HERG channels expressed in mammalian cells and find that this inward rectification arises from a rapid and voltage-dependent inactivation process that reduces conductance at positive voltages. The inactivation gating mechanism resembles that of C-type inactivation, often considered to be the 'slow inactivation' mechanism of other K+ channels. The characteristics of this gating suggest a specific role for this channel in the normal suppression of arrhythmias.

References

May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J A AndersonR F Gaber
Jun 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K L ChoiG Yellen
Apr 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·C A Vandenberg
Mar 1, 1995·The Journal of General Physiology·T Hoshi
Apr 1, 1994·Biophysical Journal·L HeginbothamR MacKinnon
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·J W Warmke, B Ganetzky

❮ Previous
Next ❯

Citations

Sep 15, 2004·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Dierk ThomasChristoph A Karle
Nov 24, 2004·Naunyn-Schmiedeberg's Archives of Pharmacology·José A Sánchez-ChapulaMichael C Sanguinetti
Jul 3, 2013·The Journal of Membrane Biology·Quentin Jamieson, Stephen W Jones
Nov 19, 2009·Histochemistry and Cell Biology·Rolando CarrisozaLaura I Escobar
Jul 12, 2007·Pflügers Archiv : European journal of physiology·Jin-Song Bian, Thomas V McDonald
May 28, 2008·Pflügers Archiv : European journal of physiology·Anders Peter LarsenThomas Jespersen
Nov 11, 2008·Pflügers Archiv : European journal of physiology·Andreas FeigenspanReto Weiler
Jun 25, 2010·Pflügers Archiv : European journal of physiology·Anders Peter Larsen
Sep 1, 1996·Pflügers Archiv : European journal of physiology·C K BauerJ R Schwarz
Mar 12, 2013·European Journal of Pharmacology·Masafumi KumazakiAkio Fujimura
Apr 27, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Amit S Dhamoon, José Jalife
Jun 28, 2005·Progress in Biophysics and Molecular Biology·Anthony VargheseDaniel C Sigg
Feb 21, 2003·Biochemical and Biophysical Research Communications·Massimo D'AmicoMassimo Olivotto
Oct 3, 2002·European Journal of Pharmacology·Anna P MalykhinaHamid I Akbarali
Dec 4, 2002·European Journal of Pharmacology·Shunichi KushidaHaruaki Nakaya
Mar 8, 2003·Journal of Molecular and Cellular Cardiology·Martin Tristani-Firouzi, Michael C Sanguinetti
Jun 1, 1997·Neuropharmacology·M C Sanguinetti, P S Spector
May 8, 2001·Trends in Pharmacological Sciences·J I VandenbergT J Campbell
Apr 16, 1998·Trends in Genetics : TIG·J L Doyle, L Stubbs
Mar 20, 2003·Bioorganic & Medicinal Chemistry Letters·John W ButcherKamlesh Vyas
Apr 3, 2001·Trends in Cardiovascular Medicine·J Kiehn
Aug 6, 2002·Trends in Cardiovascular Medicine·Martin BielChristian Wahl
May 1, 1997·Trends in Cardiovascular Medicine·A M Brown
Jul 20, 2006·Quarterly Reviews of Biophysics·Yoram Rudy, Jonathan R Silva
May 2, 2008·Chemical Research in Toxicology·John S Mitcheson
May 31, 2011·Acta Pharmacologica Sinica·Ping-zheng ZhouZhao-bing Gao
Oct 20, 2011·Nature Communications·Weihua GuanMark A Reed
Mar 21, 2008·Nature Reviews. Molecular Cell Biology·Francisco Bezanilla
Dec 21, 2010·Nature Structural & Molecular Biology·David T WangJamie I Vandenberg
Oct 9, 2007·Nature Structural & Molecular Biology·Julio F Cordero-MoralesEduardo Perozo
Sep 14, 1999·British Journal of Pharmacology·H WangZ Wang
Oct 8, 1999·British Journal of Pharmacology·A G TeschemacherH J Witchel
Aug 22, 2000·British Journal of Pharmacology·H TieT J Campbell
Nov 2, 2002·British Journal of Pharmacology·Constanze R SchererKlaus Steinmeyer
Dec 6, 2002·British Journal of Pharmacology·Teresa GonzálezCarmen Valenzuela
Oct 7, 2000·Clinical and Experimental Pharmacology & Physiology·H J Witchel, J C Hancox

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.